Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2023
Source ID
10.1016/j.ccell.2023.06.010

Entities

People

  • Atreyi Mukherji
  • Bo Li
  • Carla Rodriguez Tirado
  • Choushi Wang
  • Douglas W. Strand
  • Ganesh V Raj
  • Guanghui Zhu
  • Han Liang
  • Heewon Yoon
  • Hong Zhu
  • Housheng Hansen He
  • Jianfeng Ye
  • Joshua T. Mendell
  • Julisa Gonzalez
  • Lauren A. Metang
  • Liping Chen
  • Mia Hofstad
  • Nickolas A. Johnson
  • Peng Wei
  • Ping Mu
  • Su Deng
  • Sujun Chen
  • Tao Wang
  • Xiaoling Li
  • Xihui Liu
  • Yaru Xu
  • Yitao Tang
  • Yunguan Wang
  • Yuqiu Yang
  • Zeda Zhang
  • Zhiqun Xie

Organizations

  • Cancer Prevention and Research Institute of Texas
  • Damon Runyon Cancer Research Foundation
  • National Cancer Institute
  • National Institutes of Health
  • Prostate Cancer Foundation
  • Robert A. Welch Foundation
  • Terry Fox foundation
  • United States Department of Defense